DYRK2 and neoplasm: H&E staining and Ki-67 immunohistochemical analysis of tumor tissues indicated that knock-down of DYRK2 exhibited potent efficacy of killing tumor cells and inhibiting PCa cell proliferation (Supplementary Fig. 2f, g).